Oct 15, 2021
Two vaccines have been approved for Emergency Use Authorisation
(EUA) by the National Regulator i.e. Drugs Controller General of
India (DCGI). These are “Covishield” manufactured by Serum
Institute of India (SII) and “Covaxin” manufactured by Bharat
Biotech International Limited (BBIL). Several other vaccines are at
various stages of clinical development within the country. The
National Regulator grants Permission for Restricted Use in
Emergency Situations to Sputnik-V vaccine.
PDF: COVID-19 Vaccine: Getting
Started
Source: pib.gov.in/PressReleasePage.aspx?PRID=1711342
